Stay updated on Atrasentan in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the Atrasentan in IgA Nephropathy Clinical Trial page.

Latest updates to the Atrasentan in IgA Nephropathy Clinical Trial page
- Check3 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6. This represents a new release of the page content, typically including small edits or fixes.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page footer now displays Revision: v3.6.5, replacing the previous v3.6.4. This reflects a software version update rather than a modification to the study details.SummaryDifference0.0%

- Check38 days agoChange DetectedA new bibliographic reference for the Endothelin System in Hypertension and CKD was added to Publications/References, and the page revision was updated to v3.6.4 (replacing v3.6.3).SummaryDifference0.0%

- Check53 days agoChange DetectedAdded the final Lancet publication citation for the ALIGN IgA nephropathy results and removed the earlier online-ahead-of-print Lancet citation, updating the Publications section to reflect the final article.SummaryDifference0.0%

- Check67 days agoChange DetectedA new publication citation by Kuo et al. on atrasentan and IgA nephropathy is added to Publications. The page revision is updated to v3.6.3, reflecting updated scholarly references and versioning for the ALIGN study.SummaryDifference0.0%

- Check81 days agoChange DetectedAdds a recruitment status note indicating the trial is no longer recruiting participants and includes new navigation items such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'; removes the old 'Intervention / Treatment' label in favor of 'Intervention/Treatment' and adds the site revision note 'Revision: v3.6.0'.SummaryDifference0.2%

Stay in the know with updates to Atrasentan in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atrasentan in IgA Nephropathy Clinical Trial page.